← Leaderboards
Mikhail Nikiforov
Duke University
$14,564,827
Attributed
$14,564,827
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,564,827 · 9
By mechanism
R01$13,976,707 · 7
R21$588,120 · 2
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Rodney J Folz$5,938,014
- Christopher Dennis Kassotis$1,816,350
- Deborah M Muoio$18,719,990
- Robert Charles Noland$1,822,174
- Richard Barton Fair$4,187,013
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsProteinsRegulationOverexpressionReportingTranscription FactorMessenger RnaPhenotypeGenesMalignant NeoplasmsMediatingEnzymesMelanoma CellAnabolismNeoplasm MetastasisMelanomaMetastatic MelanomaAffectResistanceMolecularPathway InteractionsMutationXenograft ProcedureGenetic Transcription
Grant awards (46)
The role of regulation and subcellular localization of GTP biosynthesis in melanoma invasion and metastasis$499,833
R01 · FY2025 · CA · contact PI
Bidirectional control of keratinocyte differentiation and proliferation by transcription factor FOXQ1$449,379
R01 · FY2025 · AR · contact PI
Regulation and Function of Very Long Chain Fatty Acid Biosynthesis in Multiple Myeloma$385,480
R01 · FY2025 · CA · contact PI
Bidirectional control of keratinocyte differentiation and proliferation by transcription factor FOXQ1$485,781
R01 · FY2024 · AR · contact PI
The role of regulation and subcellular localization of GTP biosynthesis in melanoma invasion and metastasis$479,923
R01 · FY2024 · CA · contact PI
Regulation and Function of Very Long Chain Fatty Acid Biosynthesis in Multiple Myeloma$369,584
R01 · FY2024 · CA · contact PI
The role of regulation and subcellular localization of GTP biosynthesis in melanoma invasion and metastasis$555,172
R01 · FY2023 · CA · contact PI
Bidirectional control of keratinocyte differentiation and proliferation by transcription factor FOXQ1$513,064
R01 · FY2023 · AR · contact PI
Regulation and Function of Very Long Chain Fatty Acid Biosynthesis in Multiple Myeloma$386,435
R01 · FY2023 · CA · contact PI
GMPS-GMPR Axis Melanoma Progression and Therapy$392,357
R01 · FY2022 · CA · contact PI
Regulation and Function of Very Long Chain Fatty Acid Biosynthesis in Multiple Myeloma$391,219
R01 · FY2022 · CA · contact PI
Regulation and Function of Very Long Chain Fatty Acid Biosynthesis in Multiple Myeloma$384,326
R01 · FY2021 · CA · contact PI
GMPS-GMPR axis melanoma progression and therapy$374,421
R01 · FY2021 · CA · contact PI
GMPS-GMPR axis melanoma progression and therapy$379,998
R01 · FY2020 · CA · contact PI
KLF9-dependent pathways in multiple myeloma drug resistance$359,839
R01 · FY2020 · CA · contact PI
GMPS-GMPR axis melanoma progression and therapy$380,624
R01 · FY2019 · CA · contact PI
KLF9-dependent pathways in multiple myeloma drug resistance$370,810
R01 · FY2019 · CA · contact PI
KLF9-TXNRD2 axis in melanoma progression and metastasis$335,131
R01 · FY2019 · CA · contact PI
Inhibition of MYC interactions with chromatin-remodeling factors as a novel anti-melanoma strategy$123,054
R21 · FY2019 · CA · contact PI
KLF9-dependent pathways in multiple myeloma drug resistance$392,306
R01 · FY2018 · CA · contact PI
KLF9-TXNRD2 axis in melanoma progression and metastasis$313,945
R01 · FY2018 · CA · contact PI
GMPS-GMPR axis melanoma progression and therapy$263,046
R01 · FY2018 · CA · contact PI
GMPS-GMPR axis melanoma progression and therapy.$164,736
R01 · FY2018 · CA · contact PI
Inhibition of MYC interactions with chromatin-remodeling factors as a novel anti-melanoma strategy$126,145
R21 · FY2018 · CA · contact PI
KLF9-TXNRD2 axis in melanoma progression and metastasis$86,415
R01 · FY2018 · CA · contact PI
Inhibition of MYC interactions with chromatin-remodeling factors as a novel anti-melanoma strategy$13,135
R21 · FY2018 · CA · contact PI
KLF9-TXNRD2 axis in melanoma progression and metastasis$406,373
R01 · FY2017 · CA · contact PI
KLF9-dependent pathways in multiple myeloma drug resistance$392,306
R01 · FY2017 · CA · contact PI
Inhibition of MYC interactions with chromatin-remodeling factors as a novel anti-melanoma strategy$139,280
R21 · FY2017 · CA · contact PI
KLF9-TXNRD2 axis in melanoma progression and metastasis$406,791
R01 · FY2016 · CA · contact PI
KLF9-dependent pathways in multiple myeloma drug resistance$392,306
R01 · FY2016 · CA · contact PI
Oncogene c-Myc-dependent pathways in cutaneous melanoma03$320,405
R01 · FY2016 · CA · contact PI
Melanoma suppressing functions of carcinoma oncogene FOXQ1$186,506
R21 · FY2016 · CA · contact PI
Oncogene c-Myc-dependent pathways in cutaneous melanoma03$25,593
R01 · FY2016 · CA · contact PI
KLF9-TXNRD2 axis in melanoma progression and metastasis$406,791
R01 · FY2015 · CA · contact PI
Oncogene c-Myc-dependent pathways in cutaneous melanoma03$316,518
R01 · FY2015 · CA · contact PI
Oncogene c-Myc-dependent pathways in cutaneous melanoma03$60,479
R01 · FY2015 · CA · contact PI
Oncogene c-Myc-dependent pathways in cutaneous melanoma03$299,168
R01 · FY2014 · CA · contact PI
Oncogene c-Myc-dependent pathways in cutaneous melanoma03$34,886
R01 · FY2014 · CA · contact PI
Oncogene c-Myc-dependent pathways in cutaneous melanoma03$304,852
R01 · FY2013 · CA · contact PI
Oncogene c-Myc-dependent pathways in cutaneous melanoma03$320,646
R01 · FY2012 · CA · contact PI
Oncogene c-Myc-dependent pathways in cutaneous melanoma$320,646
R01 · FY2011 · CA · contact PI
Oncogene c-Myc-dependent pathways in cutaneous melanoma$326,468
R01 · FY2010 · CA · contact PI
Oncogene c-Myc-dependent pathways in cutaneous melanoma$322,493
R01 · FY2009 · CA · contact PI
Oncogene c-Myc-dependent pathways in cutaneous melanoma$318,635
R01 · FY2008 · CA · contact PI
Oncogene c-Myc-dependent pathways in cutaneous melanoma$287,527
R01 · FY2007 · CA · contact PI